Suppr超能文献

基于 720 个乳房植入物胶囊的包膜挛缩诊断组织病理学评分系统的建立与验证。

Development and Validation of a Diagnostic Histopathological Scoring System for Capsular Contracture Based on 720 Breast Implant Capsules.

出版信息

Aesthet Surg J. 2024 May 15;44(6):NP391-NP401. doi: 10.1093/asj/sjae050.

Abstract

BACKGROUND

Capsular contracture is traditionally evaluated with the Baker classification, but this has notable limitations regarding reproducibility and objectivity.

OBJECTIVES

The aim of this study was to develop and validate procedure-specific histopathological scoring systems to assess capsular contracture severity.

METHODS

Biopsies of breast implant capsules were used to develop histopathological scoring systems for patients following breast augmentation and breast reconstruction. Ten histological parameters were evaluated by multivariable logistic regression to identify those most associated with capsular contracture. Significant parameters (P < .05) were selected for the scoring systems and assigned weighted scores (1-10). Validation was assessed from the area under the curve (AUC) and the mean absolute error (MAE).

RESULTS

A total of 720 biopsies from 542 patients were included. Four parameters were selected for the augmentation scoring system, namely, collagen layer thickness, fiber organization, inflammatory infiltration, and calcification, providing a combined maximum score of 26. The AUC and MAE for the augmentation scoring system were 81% and 0.8%, which is considered strong. Three parameters were selected for the reconstruction scoring system, namely, fiber organization, collagen layer cellularity, and inflammatory infiltration, providing a combined maximum score of 19. The AUC and MAE of the reconstruction scoring system were 72% and 7.1%, which is considered good.

CONCLUSIONS

The new histopathological scoring systems provide an objective, reproducible, and accurate assessment of capsular contracture severity. We propose these novel scoring systems as a valuable tool for confirming capsular contracture diagnosis in the clinical setting, for research, and for implant manufacturers and insurance providers in need of a confirmed capsular contracture diagnosis.

摘要

背景

包膜挛缩传统上采用贝克分级法进行评估,但该方法在可重复性和客观性方面存在明显的局限性。

目的

本研究旨在开发和验证特定于手术的组织病理学评分系统,以评估包膜挛缩的严重程度。

方法

使用乳房植入物包膜活检来开发用于乳房增大和乳房重建后患者的组织病理学评分系统。通过多变量逻辑回归评估 10 个组织学参数,以确定与包膜挛缩最相关的参数。选择具有统计学意义的参数(P<.05)用于评分系统,并为其分配加权分数(1-10)。通过曲线下面积(AUC)和平均绝对误差(MAE)评估验证结果。

结果

共纳入 542 例患者的 720 例活检。选择了 4 个参数用于增大评分系统,即胶原层厚度、纤维组织、炎症浸润和钙化,总分为 26 分。增大评分系统的 AUC 和 MAE 分别为 81%和 0.8%,被认为具有较强的预测能力。选择了 3 个参数用于重建评分系统,即纤维组织、胶原层细胞密度和炎症浸润,总分为 19 分。重建评分系统的 AUC 和 MAE 分别为 72%和 7.1%,被认为具有良好的预测能力。

结论

新的组织病理学评分系统为包膜挛缩严重程度提供了客观、可重复和准确的评估。我们建议将这些新的评分系统作为一种有价值的工具,用于在临床环境中确认包膜挛缩的诊断,以及用于研究和需要确认包膜挛缩诊断的植入物制造商和保险公司。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验